Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
28.7M
Cash
1.025M
Avg Qtr Burn
-4.483M
Short % of Float
2.61%
Insider Ownership
44.78%
Institutional Own.
50.31%
Qtr Updated
06/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
PMN310 Details Neurodegenerative disease, Alzheimer's disease | Phase 1a Data readout |